<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) SEPTEMBER 21, 2000
------------------
ABIOMED, INC.
-------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-20584 04-2743260
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification
Number)
22 CHERRY HILL DRIVE
DANVERS, MASSACHUSETTS 01923
----------------------------
(Address of principal executive offices, including zip code)
(978) 777-5410
--------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
ITEM 5. OTHER EVENTS.
The following exhibit is filed as part of this Report:
Exhibit 99.9 Press Release dated September 21, 2000
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ABIOMED, INC.
/s/ John F. Thero
----------------------------------
Date: October 12, 2000
By: John F. Thero
Senior Vice President Finance and Treasurer
-2-
